水星家纺(603365.SH)披露第二期员工持股计划(修订稿):拟筹资总额不超1392万元
格隆汇 6 月 28日丨水星家纺(603365.SH)披露第二期员工持股计划(修订稿),本期员工持股计划的资金来源为员工合法薪酬、自筹资金以及法律、法规允许的其他方式获得的资金。
本期员工持股计划涉及的标的股票总数量不超过100万股,涉及的股票总数量约占公司现有股本总额26667万股的0.37%。拟筹集资金总额不超过1392万元,以“份”作为认购单位,每份份额为1元,本期员工持股计划的份数上限为1392万份。具体金额根据实际出资缴款金额确定。
本期员工持股计划持有人受让标的股票的价格为公司第四届董事会第九次会议召开前一交易日公司股票的收盘价13.92元/股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.